Myocardial indium-111-antimyosin uptake in essential hypertension

NuklearMedizin

Volumn 42, Issue 3, 2003, Pages 99-103

  Ünlü, Mustafa ^a,b   Temiz, N H ^a   Cengel, A ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Antimyosin; Echocardiography; Hypertension; Hypertrophy; Scintigraphy

Indexed keywords

MYOSIN ANTIBODY; MYOSIN ANTIBODY IN 111; THALLIUM 201;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HUMAN; MALE; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 11144297731     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625305     Document Type: Article

References (35)

1. Ballester M, Carrio I, Abdal ML et al. Patterns of evolution of myocyte damage after human heart transplantation detected by 111indium monoclonal antimyosin. Am J Cardiol 1988; 62: 623-7.
2. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992; 26: 671-7.
3. Brush JE, Cannon III RO, Schenke WH et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-7.
4. Cannon III RO, Watson RM, Rosing DR et al. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1989; 1: 1359-73.
5. Carrio I, Berna L, Ballester M et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1893-900.
6. Dec SW, Palacios I, Yasuda T et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990; 16: 97-104.
7. Diez J, Fortuno MA, Ravassa S. Apoptosis in hypertensive heart disease. Curr Opin Cardiol 1998; 13: 317-25.
8. Edwalds GM, Said JW, Block MI. Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability. Human Pathol 1984; 15: 753-6.
9. Flameng W, Suy R, Schwarz F. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischaemic heart disease: determinants of reversible segmental asnergy post-revascularization surgery. Am Heart J 1981; 102: 846-57.
10. Geer JC, Crago CA, Gardner LL et al. Subendocardial ischaemic myocardial lesions associated with coronary atherosclerosis. Am J Pathol 1980; 8: 663-80.
11. Gonzalez A, Lopez B, Ravassa S et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002; 39: 75-80.
12. Khaw BA, Gold HK, Yasuda T. Acute myocardial infarct imaging with indium-111 labelled monoclonal antimyosin Fab. J Nucl Med 1987; 28: 1671-8.
13. Khaw BA, Gold HK, Yasuda T. Scintigraphic quantitation of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986; 74: 501-8.
14. Koren MJ, Devereux RB, Casale PN et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
15. Laine GA. Microvascular changes in the heart during chronic arterial hypertension. Circ Res 1988; 62: 953-60.
16. Levy D, Anderson KM, Savage DD et al. Risk of ventricular arrhytmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 60: 560-5.
17. Levy D, Garrison RJ, Savage DD. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101-7.
18. Lüscher TH, Seo B, Bühler FR. Potential role of endothelin in hypertension. Hypertension 1993; 21: 747-51.
19. Motz W, Vogt M, Rabenau O. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996-1003.
20. Narula J, Kharbanda S, Khaw B. Apoptosis and the heart. Chest 1997; 112: 1358-62.
21. Narula J, Khaw BA, Dec GW. Recognition of myocarditis masquerading as acute myocardial infarction. N Engl J Med 1993; 328: 100-4.
22. Narula J, Sauthern JF, Dec GW et al. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy. J Nucl Cardiol 1995; 2: 470-7.
23. Narula J, Strauss HW, Khaw BA. Antimyosin positivity in doxorubicin toxicity: earlier than the conventional evidence. J Nucl Med 1993; 34: 1507-9.
24. Obrador D, Ballester M, Carrio I et al. High prevalence of monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989; 13: 1289-93.
25. Puig M, Ballester M, Matias-Guiu X et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histological evidence of myocyte necrosis and apoptosis. J Nucl Cardiol 2000; 7: 132-9.
26. Schiffrin EL, Devy LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993; 16: 177-86.
27. Schiffrin EL. Endothelin potential role in hypertension and vascular hypertrophy. Brief review. Hypertension 1995; 25: 1135-43.
28. Schlesinger MJ, Reiner L. Focal myocytolysis of the heart. Am J Pathol 1955; 31: 443-59.
29. Shane DJ, Demur A, Chisels J et al. The Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography. Circulation. 1978; 58: 1072-83.
30. Strauer BE. Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 1990; 65: 34G-41G.
31. The sixt report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
32. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993; 21: 747-51.
33. Weber KT, Anversa P, Armstrong PW et al. Remodelling and reparation of the cardiovascular system: an international perspective. J Am Coll Cardiol 1992; 20: 3-16.
34. Weber KT, Brilla CG. Pathological hypertrophy and the cardiac interstitium: fibrosis and the renin-angiotensin-aldosteron system. Circulation 1990; 83: 1849-65.
35. Wikstrand J. Calculation of the left ventricular mass in man-a comment. J Hypertens 1997; 15: 811-3.